Comparative study of quality of life, adverse effects after cytoreduction and HIPEC in stage IIIA-IIIC ovarian cancer

Comparative study of quality of life, adverse effects after cytoreduction and HIPEC in stage IIIA-IIIC ovarian cancer

Nowadays cytorective surgery and HIPEC is the mainstay of management of advanced stages ovarian cancer. Study was conducted to assess the effectiveness of combined treatment in IIIA-IIIC ovarian cancer, its impact on quality of life. 37 patients of main group (CRS + HIPEC) were compared with 25 pati...

Full description

Bibliographic Details
Main Authors:	A. I. Rybin, V. Y. Maksymovskyj, V. V. Pyrogov, R. Ya. Demidchik, A. O. Varabina
Format:	Article
Language:	English
Published:	Kazimierz Wielki University 2018-10-01
Series:	Journal of Education, Health and Sport
Subjects:	ovarian cancer, treatment, hipec, cytoreduction, chemotherapy
Online Access:	http://www.ojs.ukw.edu.pl/index.php/johs/article/view/6398

Similar Items

THE EXPERIENCE AND RESULTS OF CYTOREDUCTIVE SURGERY AND HIPEC USED IN ADVANCED OVARIAN CANCER
by: Oleksandr Bondar, et al.
Published: (2020-10-01)

The prognosis impact of hyperthermic intraperitoneal chemotherapy (HIPEC) plus cytoreductive surgery (CRS) in advanced ovarian cancer: the meta-analysis
by: Guyu Zhang, et al.
Published: (2019-04-01)

Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease
by: Juan José Segura-Sampedro, et al.
Published: (2020-05-01)

The outcomes of isolated ureteral resection and reconstruction in non-urologic cancer patients who underwent cytoreductive surgery (CRC) and hyperthermic intraperitoneal chemotherapy (HIPEC)
by: Şevket Barış Morkavuk, et al.
Published: (2019-12-01)

EXPERIENCE IN APPLYING THE TECHNOLOGY OF CYTOREDUCTIVE SURGERY WITH HYPERTHERMIC INTRAOPERATIVE INTRAPERITONEAL CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH PERITONEAL CARCINOMATOSIS
by: A. V. Shelekhov, et al.
Published: (2018-07-01)

Post-operative critical care management of patients undergoing cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC)
by: Cooksley Timothy J, et al.
Published: (2011-12-01)

Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients
by: Anna Weiss, et al.
Published: (2018-04-01)

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
by: Andrea Jewell, et al.
Published: (2018-09-01)

Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Epithelial Ovarian Cancer: A 20-Year Single-Center Experience
by: Fabio Carboni, et al.
Published: (2021-01-01)

A Four-Inflow Construction to Ensure Thermal Stability and Uniformity during Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Rats
by: Daan R. Löke, et al.
Published: (2020-11-01)

IS HIPEC BENEFICIAL IN PLATINUM RESISTANT RELAPSED OVARIAN CANCER?
by: Nicolae Bacalbasa, et al.
Published: (2019-09-01)

Neoadjuvant chemotherapy for IIIC stage ovarian cancer - case report
by: Aleksandra Obuchowska, et al.
Published: (2020-09-01)

Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges
by: Roxan F. C. P. A. Helderman, et al.
Published: (2021-07-01)

Enhanced recovery after surgery (ERAS) in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a cross-sectional survey
by: Bhandoria Geetu, et al.
Published: (2021-06-01)

Laparoscopic HIPEC: A bridge between open and closed-techniques
by: Marco Lotti, et al.
Published: (2016-01-01)

Quality of life outcomes from the randomized trial of hyperthermic intraperitoneal chemotherapy following cytoreductive surgery for primary ovarian cancer (KOV-HIPEC-01)
by: Chang, S.-J, et al.
Published: (2022)

Effect of Preoperative Immunonutrition on Postoperative Major Morbidity after Cytoreductive Surgery and HIPEC in Patients with Peritoneal Metastasis
by: Alba Fernández-Candela, et al.
Published: (2021-06-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases – The Hong Kong experience and literature review
by: Felix Che-lok Chow, et al.
Published: (2021-01-01)

Feasibility and outcomes of cytoreductive surgery and HIPEC for peritoneal surface malignancies in low- and middle-income countries: a single-center experience of 232 cases
by: Suryanarayana Deo, et al.
Published: (2021-06-01)

Clinical Utility of Preoperative Assessment in Ovarian Cancer Cytoreduction
by: Pratistha Koirala, et al.
Published: (2020-08-01)

Sodium thiosulfate protects from renal impairement following hyperthermic intraperitoneal chemotherapy (HIPEC) with Cisplatin
by: N. Laplace, et al.
Published: (2020-01-01)

Cytoreductive surgery and HIPEC (hyperthermic intraperitoneal chemotherapy) in combined treatment of ovarian cancer: time for the beginning of personalized therapy?
by: Yarema Roman, et al.
Published: (2019-09-01)

Hyperthermic intraoperative thoracoabdominal chemotherapy for stage IVB epithelial ovarian carcinoma
by: Alexandre Brind'Amour, et al.
Published: (2020-11-01)

Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort
by: Vahan Kepenekian, et al.
Published: (2021-01-01)

Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience
by: Francesco Santullo, et al.
Published: (2021-08-01)

The role of cytoreduction surgery in advanced ovarian cancer (review)
by: R K Tandelov, et al.
Published: (2018-03-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer
by: Loss Martin, et al.
Published: (2004-06-01)

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II)
by: W. J. Koemans, et al.
Published: (2019-05-01)

Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer
by: Blair McNamara, et al.
Published: (2021-11-01)

Anesthesiological support of cytoreducative operations using hyperthermic intraperitoneal chemotherapy (hipec) in patients with ovaryan cancer
by: D. D. Morikov, et al.
Published: (2019-11-01)

Quaternary and beyond cytoreduction: An updated and expanded analysis
by: Beryl L. Manning-Geist, et al.
Published: (2021-08-01)

Enhanced Recovery After Surgery for Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Systematic Review and Meta-Analysis
by: Feng Mao, et al.
Published: (2021-07-01)

Data on the quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: does it concern patients with gastric cancer?
by: Skierucha Malgorzata, et al.
Published: (2017-12-01)

Evaluation of staging, cytoreduction and second-look operation of 119 ovarian cancer patients
by: Eddie Fernando Candido Murta, et al.

Cytoreductive surgery including distal pancreatectomy with splenectomy in advanced stage ovarian cancer: Two centers analysis
by: Anil Erturk, et al.
Published: (2020-11-01)

The evolution of hyperthermic intraperitoneal chemotherapy in the setting of advanced ovarian cancer
by: Quindlen, Kevin John
Published: (2019)

Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept
by: Olivia Sgarbura, et al.
Published: (2020-01-01)

Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients
by: Costa Wilson L, et al.
Published: (2012-09-01)

Patient selection for cytoreductive surgery and HIPEC for the treatment of peritoneal metastases from colorectal cancer
by: Simkens GA, et al.
Published: (2017-06-01)

Hyperthermic intraperitoneal chemotherapy enhances blood coagulation perioperatively evaluated by thromboelastography: a pilot study
by: Mari Tuovila, et al.
Published: (2020-01-01)